Randomized Controlled Trial
Copyright ©The Author(s) 2021.
World J Gastroenterol. Jan 7, 2021; 27(1): 107-128
Published online Jan 7, 2021. doi: 10.3748/wjg.v27.i1.107
Table 1 Demographic data of study subjects
Probiotic-treated group (n = 30)
Placebo group (n = 30)
P value
Age (yr)44.07 ± 6.2344.67 ± 5.660.421
Height (cm)159.66 ± 8.27157.92 ± 9.580.401
Weight (kg)83.45 ± 14.6179.58 ± 11.790.211
BMI (kg/m2)32.69 ± 5.0731.88 ± 3.770.181
Women, n (%)18 (60)18 (60)0.002
Men, n (%)12 (40)12 (40)0.002
1Independent sample t-test.
2Chi-square. BMI: Body mass index.
  • Citation: Rahayu ES, Mariyatun M, Putri Manurung NE, Hasan PN, Therdtatha P, Mishima R, Komalasari H, Mahfuzah NA, Pamungkaningtyas FH, Yoga WK, Nurfiana DA, Liwan SY, Juffrie M, Nugroho AE, Utami T. Effect of probiotic Lactobacillus plantarum Dad-13 powder consumption on the gut microbiota and intestinal health of overweight adults. World J Gastroenterol 2021; 27(1): 107-128
  • URL: https://www.wjgnet.com/1007-9327/full/v27/i1/107.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v27.i1.107